Sachpekidis, Christos http://orcid.org/0000-0001-8739-8741
Enqvist, Olof
Ulén, Johannes
Kopp-Schneider, Annette
Pan, Leyun
Mai, Elias K.
Hajiyianni, Marina
Merz, Maximilian
Raab, Marc S.
Jauch, Anna
Goldschmidt, Hartmut
Edenbrandt, Lars
Dimitrakopoulou-Strauss, Antonia
Funding for this research was provided by:
Deutsches Krebsforschungszentrum (DKFZ)
Article History
Received: 18 December 2023
Accepted: 25 February 2024
First Online: 8 March 2024
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all participants enrolled in the study.
: Consent to publish has been received from all participants.
: Hartmut Goldschmidt declares the following:Grants and/or provision of Investigational Medicinal Product: Amgen, Array Biopharma/Pfizer, BMS/Celgene, Chugai, Dietmar-Hopp Foundation, Janssen, Johns Hopkins University, Mundipharma GmbH, Sanofi.Research support: Amgen, BMS, Celgene, GlycoMimetics Inc., GSK, Heidelberg Pharma, Hoffmann-La Roche, Karyopharm, Janssen, Incyte Corporation, Millenium Pharmaceuticals Inc., Molecular Partners, Merck Sharp and Dohme (MSD), MorphoSys AG, Pfizer, Sanofi, Takeda, Novartis.Advisory boards: Amgen, BMS, Janssen, Sanofi, Adaptive Biotechnology.Honoraria: Amgen, BMS, Chugai, GlaxoSmithKline (GSK), Janssen, Novartis, Sanofi, Pfizer.Support for attending meetings and/or travel: Amgen, BMS, GlaxoSmithKline (GSK), Janssen, Novartis, Sanofi, Pfizer.Elias K. Mai reports the following:Consulting or advisory role: Bristol Myers Squibb/Celgene, GlaxoSmithKline, Janssen-Cilag, Sanofi Aventis, Stemline, Takeda.Honoraria: Bristol Myers Squibb/Celgene, GlaxoSmithKline, Janssen-Cilag, Sanofi Aventis, Stemline, Takeda.Research funding: Sanofi Aventis.Travel accommodations and expenses: Bristol Myers Squibb/Celgene, GlaxoSmithKline, Janssen-Cilag, Sanofi Aventis, Stemline, Takeda.All other authors declare no conflicts of interest.